PaperHypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus
References (26)
- et al.
Diabetes mellitus, vascular disease and thrombosis
Clinics in Haematology
(1986) - et al.
Fibrinolytic activity and treatment of diabetes
Lancet
(1974) Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies
Anal Biochem
(1966)- et al.
Quantitation of tissue type plasminogen activator in human endothelial cultures by use of an enzyme immunoassay
Thromb Res
(1984) - et al.
Features on endothelial dysfunction in early diabetic nephropathy
Lancet
(1989) - et al.
Plasminogen activator inhibitor in plasma risk factor for recurrent myocardial infarction
Lancet
(1987) - et al.
Diabetes mortality from vital statistics
- et al.
Diabetes, a hypercoagulable state?
Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in juvenile onset and maturity onset diabetes mellitus
J Clin Pathol
(1981)- et al.
On fibrinolysis in diabetes mellitus
Acta Med Scand
(1975)
Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity
Brit Med J
Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus
Arteriosclerosis
Nonenzymatic glycosilation and the pathogenesis of diabetic complications
Ann Int Med
Cited by (70)
Detection of early allograft dysfunction at 30 min of reperfusion in liver transplantation: An intraoperative diagnostic tool with real time assessment of graft function
2020, American Journal of SurgeryCitation Excerpt :A fibrinolytic response can be generated in healthy individuals by applying a tourniquet to the arm promoting the release of tPA and this results in increased local fibrinolytic activity in the ischemic arm.32 Hypofibrinolysis, defined by this measurement has been associated with thrombotic complications in multiple clinical settings.32–34 Liver transplant serves as another model for identifying hypofibrinolysis, as removal of the liver results in lack of clearance of tPA, and therefore it would be expected that all liver transplant patients would experience hyperfibrinolysis during the anhepatic phase of surgery.
The potent different risk factors for cerebral infarction in young patients with and without type 2 diabetes: Subanalysis of the Young Cerebral Infarction Study (YCIS)
2012, AtherosclerosisCitation Excerpt :However, it is possible to speculate that the diabetes induced increasing level of serum fibrinogen render the cerebral vessels prone to block. In diabetic patients, platelet aggregability, coagulability, and plasminogen activator inhibitor levels are increased, whereas fibrinolytic activity is decreased [21,22]. Initial stroke severity did not differ between diabetic and non-diabetic patients, in agreement with a hospital-based series that found diabetic individuals had more severe strokes [18] and a poorer neurologic outcome [23]; however, the number of known diabetics studied was very small.